Medadvisor Ltd
ASX:MDR

Watchlist Manager
Medadvisor Ltd Logo
Medadvisor Ltd
ASX:MDR
Watchlist
Price: 0.22 AUD 4.76% Market Closed
Market Cap: 121.3m AUD
Have any thoughts about
Medadvisor Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one MDR stock under the Base Case scenario is 0.3 AUD. Compared to the current market price of 0.22 AUD, Medadvisor Ltd is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MDR Relative Value
Base Case
0.3 AUD
Undervaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1
P/S
P/S
Price to Sales
1
vs History
69
vs Industry
41
Median 3Y
1.1
Median 5Y
2
Industry
2.3
Forward
0.8
More Details
152.9
P/E
P/E
Price to Earnings
152.9
vs History
6
vs Industry
Median 3Y
-9
Median 5Y
-10.2
Industry
23.1
Forward
54.4
More Details
23.3
P/OCF
P/OCF
Price to OCF
23.3
vs History
6
vs Industry
42
Median 3Y
-13.2
Median 5Y
-13.6
Industry
14.2
More Details
31.8
P/FCFE
P/FCFE
Price to FCFE
31.8
vs History
7
vs Industry
35
Median 3Y
-13.2
Median 5Y
-15.2
Industry
20.1
More Details
2.3
P/B
P/B
Price to Book Value
2.3
vs History
47
vs Industry
12
Median 3Y
2.6
Median 5Y
2.7
Industry
2.2
More Details
0.9
EV/S
EV/S
Enterprise Value to Sales
0.9
vs History
82
vs Industry
41
Median 3Y
1.2
Median 5Y
1.9
Industry
2.4
Forward
0.7
More Details
1.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.4
vs History
87
vs Industry
45
Median 3Y
2
Median 5Y
3.1
Industry
5
More Details
39.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
39.1
vs History
6
vs Industry
Median 3Y
-8.9
Median 5Y
-9.4
Industry
12.7
Forward
13.2
More Details
39.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
39.1
vs History
6
vs Industry
Median 3Y
-8.9
Median 5Y
-9.4
Industry
17.1
Forward
36.5
More Details
20.3
EV/OCF
EV/OCF
Enterprise Value to OCF
20.3
vs History
6
vs Industry
44
Median 3Y
-13.4
Median 5Y
-12.3
Industry
14
More Details
31.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
31.5
vs History
6
vs Industry
37
Median 3Y
-13
Median 5Y
-12
Industry
18
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
58
vs Industry
21
Median 3Y
1.5
Median 5Y
1.7
Industry
1.9
More Details

Multiples Across Competitors

MDR Competitors Multiples
Medadvisor Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Medadvisor Ltd
ASX:MDR
121.1m AUD 1 152.9 39.1 39.1
US
Veeva Systems Inc
NYSE:VEEV
35.6B USD 13.7 54.5 46.4 49.2
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
26.1B AUD 157.1 315.6 220.8 220.8
US
Doximity Inc
NYSE:DOCS
10.8B USD 21 62.4 47.4 49.8
US
Waystar Holding Corp
NASDAQ:WAY
6.4B USD 7 -120.8 24.7 68.9
JP
M3 Inc
TSE:2413
934B JPY 3.8 23.9 11.8 13.8
US
Inspire Medical Systems Inc
NYSE:INSP
5.6B USD 7.4 170.1 283.4 386
SE
Sectra AB
STO:SECT B
53.2B SEK 29.4 118.9 -71.1 -71.1
US
Vocera Communications Inc
F:V00
2.4B EUR 10.7 -293.9 238.8 3 823.1
CN
Winning Health Technology Group Co Ltd
SZSE:300253
16B CNY 5 44.5 32.4 32.4
P/E Multiple
Earnings Growth P/E to Growth
AU
Medadvisor Ltd
ASX:MDR
Average P/E: 110.7
152.9
1 489%
0.1
US
Veeva Systems Inc
NYSE:VEEV
54.5
142%
0.4
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
315.6
131%
2.4
US
Doximity Inc
NYSE:DOCS
62.4
78%
0.8
US
W
Waystar Holding Corp
NASDAQ:WAY
Negative Multiple: -120.8 N/A N/A
JP
M3 Inc
TSE:2413
23.9
33%
0.7
US
Inspire Medical Systems Inc
NYSE:INSP
170.1
N/A N/A
SE
Sectra AB
STO:SECT B
118.9
81%
1.5
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -293.9 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
44.5
142%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Medadvisor Ltd
ASX:MDR
Average EV/EBITDA: 96.7
39.1
855%
0
US
Veeva Systems Inc
NYSE:VEEV
46.4
221%
0.2
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
220.8
130%
1.7
US
Doximity Inc
NYSE:DOCS
47.4
92%
0.5
US
W
Waystar Holding Corp
NASDAQ:WAY
24.7
N/A N/A
JP
M3 Inc
TSE:2413
11.8
24%
0.5
US
Inspire Medical Systems Inc
NYSE:INSP
283.4
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -71.1 N/A N/A
US
V
Vocera Communications Inc
F:V00
238.8
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
32.4
143%
0.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Medadvisor Ltd
ASX:MDR
Average EV/EBIT: 472.6
39.1
659%
0.1
US
Veeva Systems Inc
NYSE:VEEV
49.2
239%
0.2
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
220.8
122%
1.8
US
Doximity Inc
NYSE:DOCS
49.8
102%
0.5
US
W
Waystar Holding Corp
NASDAQ:WAY
68.9
N/A N/A
JP
M3 Inc
TSE:2413
13.8
N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
386
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -71.1 N/A N/A
US
V
Vocera Communications Inc
F:V00
3 823.1
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
32.4
123%
0.3

See Also

Summary
MDR intrinsic value, competitors valuation, and company profile.
DCF Valuation
MDR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MDR stock valuation using valuation multiples.
Wall Street Estimates
MDR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MDR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.